Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, December 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 509 followers.

RT @JournalofExper1: 📍𝐂𝐡𝐢𝐝𝐚𝐦𝐢𝐝𝐞 increases the sensitivity of refractory or relapsed 𝐚𝐜𝐮𝐭𝐞 𝐦𝐲𝐞𝐥𝐨𝐢𝐝 𝐥𝐞𝐮𝐤𝐞𝐦𝐢𝐚 cells to anthracyclines via regu…

06 Jan 2021

Reply Repost Favourite

📍𝐂𝐡𝐢𝐝𝐚𝐦𝐢𝐝𝐞 increases the sensitivity of refractory or relapsed 𝐚𝐜𝐮𝐭𝐞 𝐦𝐲𝐞𝐥𝐨𝐢𝐝 𝐥𝐞𝐮𝐤𝐞𝐦𝐢𝐚 cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway #Chidamide #AcuteMyeloidLeukemia Read here ⬇️ https://t.co/X65r8NnmAD https://t.co/D

05 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.